A new measles mumps rubella (MMR) vaccine: a randomized comparative trial for assessing the reactogenicity and immunogenicity of three consecutive production lots and comparison with a widely used MMR vaccine in measles primed children.
about
Assessing mumps outbreak risk in highly vaccinated populations using spatial seroprevalence data.Safety and Immunogenicity of Human Serum Albumin-Free MMR Vaccine in US Children Aged 12-15 Months.Long time immunogenicity of measles vaccine in the vaccination era: An open question.Immunogenicity and safety of a novel MMR vaccine (live, freeze-dried) containing the Edmonston-Zagreb measles strain, the Hoshino mumps strain, and the RA 27/3 rubella strain: Results of a randomized, comparative, active controlled phase III clinica
P2860
A new measles mumps rubella (MMR) vaccine: a randomized comparative trial for assessing the reactogenicity and immunogenicity of three consecutive production lots and comparison with a widely used MMR vaccine in measles primed children.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
A new measles mumps rubella (M ...... ne in measles primed children.
@en
A new measles mumps rubella
@nl
type
label
A new measles mumps rubella (M ...... ne in measles primed children.
@en
A new measles mumps rubella
@nl
prefLabel
A new measles mumps rubella (M ...... ne in measles primed children.
@en
A new measles mumps rubella
@nl
P2093
P1476
A new measles mumps rubella (M ...... ne in measles primed children.
@en
P2093
Fu-Yuan Huang
Haiwen Tang
Hans L Bock
Ren-Bin Tang
P304
P356
10.1016/S1201-9712(02)90112-8
P577
2002-09-01T00:00:00Z